Once-a-week injection achieved less weight loss than rival treatment
Italys F2i Fund Nears 1 Billion on Europe Infrastructure Push
...
Read moreDetailsHome » Novo Nordisk shares drop 15% after poor trial results for new obesity drug
Once-a-week injection achieved less weight loss than rival treatment
...
Read moreDetails